<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="sub-section" /><meta name="keywords" content="Macrolides; Legionnaires’ disease; Chlamydia: macrolides, in; Erythromycin; Azithromycin; Clarithromycin; Spiramycin" /><meta name="IX" content="Macrolides; Legionnaires’ disease; Chlamydia: macrolides, in; Erythromycin; Azithromycin; Clarithromycin; Spiramycin" /><title>5.1.5 Macrolides: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="3849.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="3849.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=3849.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2071.htm">5 Infections</a> &gt; <a href="3705.htm">5.1 Antibacterial drugs</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="3847.htm" title="Previous: TOBRAMYCIN">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="3859.htm" title="Next: AZITHROMYCIN">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_3849">5.1.5 Macrolides</h1><?highlighter on?><div id="pC" class="jN"><div><p>The macrolides have an antibacterial spectrum that is similar but
not identical to that of penicillin; they are thus an alternative
in penicillin-allergic patients. They are active against many-penicillin-resistant
staphylococci, but some are now also resistant to the macrolides.</p><p>Indications for the macrolides include campylobacter enteritis,
respiratory infections (including pneumonia, whooping cough, Legionella, chlamydia, and mycoplasma
infection), and skin infections.</p><p><b>Erythromycin</b> is also used in the treatment of early syphilis, uncomplicated genital
chlamydial infection, and non-gonococcal urethritis. Erythromycin
has poor activity against <span class="cAC">Haemophilus influenzae</span>. Erythromycin causes nausea, vomiting, and diarrhoea in some patients;
in mild to moderate infections this can be avoided by giving a lower
dose (250 mg 4 times daily), but if a more serious infection, such
as Legionella pneumonia, is suspected higher doses are needed.</p><p><b>Azithromycin</b> is a macrolide with slightly less activity than erythromycin against
Gram-positive bacteria, but enhanced activity against some Gram-negative
organisms including <span class="cAC">H. influenzae</span>. Plasma concentrations
are very low, but tissue concentrations are much higher. It has a
long tissue half-life and once daily dosage is recommended. Azithromycin
is also used in the treatment of uncomplicated genital chlamydial
infection, non-gonococcal urethritis, uncomplicated gonorrhoea, typhoid
[unlicensed indication], and trachoma [unlicensed indication] (<a title="BNF:sub-section: Antibacterials" href="5373.htm#_5373">section 11.3.1</a>).</p><p><b>Clarithromycin</b> is an erythromycin derivative with slightly greater activity than
the parent compound. Tissue concentrations are higher than with erythromycin.
It is given twice daily. Clarithromycin is also used in regimens for <span class="cAC">Helicobacter pylori</span> eradication (<a title="BNF:topic: Helicobacter pylori  infection" href="60264.htm#_60264">section 1.3</a>).</p><p>For the role of erythromycin, azithromycin, and clarithromycin
in the treatment of Lyme disease, see <a title="BNF:target-block: lymedisease" href="3723.htm#_3723.4">section 5.1.1.3</a></p><p><b>Spiramycin</b> is also a macrolide (<a title=" Drugs for toxoplasmosis" href="4052.htm#_4052">section 5.4.7</a>).</p><div id="_3849.3"><div class="cAZ" id="_213712"><h2>Oral infections</h2> <p class="cAX">The macrolides are an alternative
for oral infections in penicillin-allergic patients or where a beta-lactamase
producing organism is involved. However, many organisms are now resistant
to macrolides or rapidly develop resistance; their use should therefore
be limited to short courses. Metronidazole (<a title="sub-section: Metronidazole and tinidazole" href="3931.htm#_3931">section 5.1.11</a>) may
be preferred as an alternative to a penicillin.</p><div class="cAZ"><h2>Cautions</h2> <p class="cAX">Macrolides should be used
with caution in patients with a predisposition to QT interval prolongation
(including electrolyte disturbances and concomitant use of drugs that
prolong the QT interval). Macrolides may aggravate myasthenia
gravis. </p></div></div></div><div id="_207792"><div class="cAZ"><h2>Side-effects</h2> <p class="cAX">Nausea, vomiting, abdominal discomfort,
and diarrhoea are the most common side-effects of the macrolides,
but they are mild and less frequent with azithromycin and clarithromycin
than with erythromycin. Hepatotoxicity (including cholestatic jaundice)
and rash occur less frequently. Other side-effects reported rarely
or very rarely include pancreatitis, antibiotic-associated colitis,
QT interval prolongation, arrhythmias, Stevens-Johnson syndrome, and
toxic epidermal necrolysis. Generally reversible hearing loss (sometimes
with tinnitus) has been reported after large doses of a macrolide; it occurs commonly after long-term therapy with azithromycin.
Intravenous infusion may cause local tenderness and phlebitis.</p></div></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_3859"><a href="3859.htm" title="AZITHROMYCIN">AZITHROMYCIN</a></li><li id="_3861"><a href="3861.htm" title="CLARITHROMYCIN">CLARITHROMYCIN</a></li><li id="_3850"><a href="3850.htm" title="ERYTHROMYCIN">ERYTHROMYCIN</a></li><li id="_207784"><a href="207784.htm" title="Telithromycin">Telithromycin</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="3847.htm">Previous: TOBRAMYCIN</a> | <a class="top" href="3849.htm#">Top</a> | <a accesskey="]" href="3859.htm">Next: AZITHROMYCIN</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>